Merck + Google Cloud Deal

- Merck announced a deal to deploy Google Cloud's Gemini Enterprise to accelerate agentic AI across drug development and operations. - The collaboration is described as a large-scale partnership involving significant cloud and AI procurement and implementation workstreams. - This signals enterprise-grade agentic AI adoption with questions about rollout timelines and data residency for pilots versus production. (merck.com)

Merck said April 22 it will deploy Google Cloud’s Gemini Enterprise across drug development and operations as part of a broader artificial intelligence overhaul. (merck.com) The companies announced the deal at Google Cloud Next 2026 in Las Vegas, and Merck said the rollout will span its “digital backbone” across discovery, clinical development and commercialization. Google Cloud said Merck is building a Gemini Enterprise-powered “agentic engine” to support decision-making across that chain. (merck.com) (cloud.google.com) Agentic artificial intelligence means software that does more than answer prompts: it can pull data, follow rules, coordinate steps and hand work back to people. Google introduced Gemini Enterprise six months ago as a workplace platform with tools including Agent Designer, long-running agents and centralized controls for permissions and policies. (cloud.google.com 1) (cloud.google.com 2) Merck framed the partnership as more than a pilot. Its release described “significant cloud and AI procurement and implementation workstreams,” language that points to paid infrastructure, software and integration work rather than a limited experiment. (merck.com) The timing lands as drugmakers push artificial intelligence into research and back-office work while patent cliffs pressure costs and speed. Merck spent $15.8 billion on research and development in 2025 and guided for $65.5 billion to $67.0 billion in 2026 sales, giving the company both a large science budget and an incentive to shorten development cycles. (merck.com) Merck was already using artificial intelligence before this deal. The company said in January that more than 80% of its workforce uses its internal artificial intelligence platform to automate and simplify work, and the new Google Cloud agreement extends that push into enterprise systems and regulated workflows. (merck.com) The unresolved part is where data sits and how fast Merck moves from pilots to production. Google Cloud says Gemini Enterprise supports data residency at rest in listed United States, European Union and in-country regions, but it also lists limitations, and some security features such as customer-managed encryption keys are not available in the global location. (cloud.google.com) Google Cloud also markets Gemini Enterprise with controls aimed at regulated industries, including Virtual Private Cloud Service Controls, customer-managed encryption keys, Access Transparency and support for workloads such as the Health Insurance Portability and Accountability Act and FedRAMP High in certain editions. Those features matter for a pharmaceutical company handling research, clinical and operational data across multiple jurisdictions. (cloud.google.com) Neither company disclosed contract value, deployment dates or which Merck functions will go live first. The next test is whether this April 22 announcement becomes a production rollout with named use cases, regional controls and measurable changes in how Merck develops and runs medicines. (merck.com)

Get your own daily briefing

Scout delivers personalized news, insights, and conversations tailored to your role and industry.

Download on the App Store

Shared from Scout - Be the smartest in the room.